{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:48:28Z","timestamp":1793296108624,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.cbi.2025.111408","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T08:40:55Z","timestamp":1738226455000},"page":"111408","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Inhibition of p75NTR\/p53 axis by ambrisentan suppresses apoptosis and oxidative stress-mediated renal damage in a cisplatin AKI model"],"prefix":"10.1016","volume":"408","author":[{"given":"Mirhan N.","family":"Makled","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noran N.","family":"Makled","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.","family":"Abdel-Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1958-2605","authenticated-orcid":false,"given":"Maha H.","family":"Sharawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2025.111408_bib1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1023\/A:1006490226104","article-title":"A randomized trial comparing the nephrotoxicity of cisplatin\/ifosfamide-based combination chemotherapy with or without amifostine in patients with solid tumors","volume":"18","author":"Hartmann","year":"2000","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.cbi.2025.111408_bib2","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1517\/14656566.4.6.889","article-title":"Toxicity of platinum compounds","volume":"4","author":"Hartmann","year":"2003","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.cbi.2025.111408_bib3","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.3390\/toxins2112490","article-title":"Mechanisms of cisplatin nephrotoxicity","volume":"2","author":"Miller","year":"2010","journal-title":"Toxins"},{"key":"10.1016\/j.cbi.2025.111408_bib4","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1080\/08880010590964381","article-title":"Severe neurotoxicity, ototoxicity and nephrotoxicity following high-dose cisplatin and amifostine","volume":"22","author":"Sastry","year":"2005","journal-title":"Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.cbi.2025.111408_bib5","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13568-020-00993-w","article-title":"Kaempferol ameliorates Cisplatin induced nephrotoxicity by modulating oxidative stress, inflammation and apoptosis via ERK and NF-\u03baB pathways","volume":"10","author":"Wang","year":"2020","journal-title":"Amb. Express"},{"key":"10.1016\/j.cbi.2025.111408_bib6","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1139\/Y08-059","article-title":"Endothelin: 20 years from discovery to therapy","volume":"86","author":"Barton","year":"2008","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.cbi.2025.111408_bib7","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1146\/annurev.pharmtox.47.120505.105134","article-title":"Contrasting actions of endothelin ET(A) and ET(B) receptors in cardiovascular disease","volume":"47","author":"Schneider","year":"2007","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.cbi.2025.111408_bib8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.semnephrol.2015.02.004","article-title":"Endothelin and the renal microcirculation","volume":"35","author":"Guan","year":"2015","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.cbi.2025.111408_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043427","article-title":"Endothelin receptor antagonists in kidney disease","volume":"24","author":"Mart\u00ednez-D\u00edaz","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2025.111408_bib10","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/bcp.12064","article-title":"Endothelin antagonists for diabetic and non-diabetic chronic kidney disease","volume":"76","author":"Kohan","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.cbi.2025.111408_bib11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/MNH.0000000000000185","article-title":"Endothelin-1 and the kidney: new perspectives and recent findings","volume":"25","author":"De Miguel","year":"2016","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.cbi.2025.111408_bib12","first-page":"547","article-title":"Comparison of the protective effects of selective endothelin-a receptor antagonist, ambrisentan, and dual endothelin-A\/B receptor antagonist, bosentan, in experimental renal ischemia reperfusion injury","volume":"121","author":"Kazimoglu","year":"2020","journal-title":"Bratisl. Lek. Listy"},{"key":"10.1016\/j.cbi.2025.111408_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.105905","article-title":"Pulmonary hypertension in end-stage renal disease","volume":"164","author":"Devasahayam","year":"2020","journal-title":"Respir. Med."},{"key":"10.1016\/j.cbi.2025.111408_bib14","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/nep.14130","article-title":"Endothelin receptor antagonists in kidney protection for diabetic kidney disease and beyond?","volume":"28","author":"Chung","year":"2023","journal-title":"Nephrology"},{"key":"10.1016\/j.cbi.2025.111408_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9101406","article-title":"Cisplatin mouse models: treatment, toxicity and translatability","volume":"9","author":"Per\u0161e","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.cbi.2025.111408_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-72960-1","article-title":"Ambrisentan, an endothelin receptor type A-selective antagonist, inhibits cancer cell migration, invasion, and metastasis","volume":"10","author":"Kappes","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2025.111408_bib17","series-title":"Theory and practice of histological techniques","author":"Bancroft","year":"2008"},{"key":"10.1016\/j.cbi.2025.111408_bib18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fphys.2017.00093","article-title":"Effects of topical icing on inflammation, angiogenesis, revascularization, and myofiber regeneration in skeletal muscle following contusion injury","volume":"8","author":"Singh","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.cbi.2025.111408_bib19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0009-8981(78)90081-5","article-title":"Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method","volume":"90","author":"Kei","year":"1978","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cbi.2025.111408_bib20","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.cbi.2025.111408_bib21","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/jcp.54.5.356","article-title":"Method for the measurement of antioxidant activity in human fluids","volume":"54","author":"Koracevic","year":"2001","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.cbi.2025.111408_bib22","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0006-291X(72)80218-3","article-title":"The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen","volume":"46","author":"Nishikimi","year":"1972","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cbi.2025.111408_bib23","series-title":"Determination of Nitrite in Water, ROYAL SOC CHEMISTRY THOMAS GRAHAM HOUSE, Science Park, Milton Rd","first-page":"414","author":"Montgomery","year":"1961"},{"key":"10.1016\/j.cbi.2025.111408_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120845","article-title":"The modulatory effect of sodium molybdate against cisplatin-induced CKD: role of TGF-\u03b2\/Smad signaling pathway","volume":"306","author":"El-Waseif","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.cbi.2025.111408_bib25","series-title":"Clinical and Experimental Nephrology","article-title":"An integrated view of cisplatin-induced nephrotoxicity, hepatotoxicity, and cardiotoxicity: characteristics, common molecular mechanisms, and current clinical management","author":"Oliveira","year":"2024"},{"key":"10.1016\/j.cbi.2025.111408_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116797","article-title":"Ketotifen counteracts cisplatin-induced acute kidney injury in mice via targeting NF-\u03baB\/NLRP3\/Caspase-1 and Bax\/Bcl2\/Caspase-3 signaling pathways","volume":"175","author":"Mohtadi","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cbi.2025.111408_bib27","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.cbi.2018.05.015","article-title":"Venlafaxine mitigates cisplatin-induced nephrotoxicity via down-regulating apoptotic pathway in rats","volume":"290","author":"El-Kashef","year":"2018","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2025.111408_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.111255","article-title":"CGS-21680 defers cisplatin-induced AKI-CKD transition in C57\/BL6 mice","volume":"403","author":"Elbrolosy","year":"2024","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2025.111408_bib29","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1006\/phrs.2000.0724","article-title":"Effects of the antioxidants curcumin or selenium on cisplatin-induced nephrotoxicity and lipid peroxidation in rats","volume":"43","author":"Antunes","year":"2001","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.cbi.2025.111408_bib30","first-page":"121","article-title":"Hydrogen sulfide ameliorates the kidney dysfunction and damage in cisplatin-induced nephrotoxicity in rat","volume":"5","author":"Ahangarpour","year":"2014","journal-title":"Vet. Res. Forum"},{"key":"10.1016\/j.cbi.2025.111408_bib31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s41232-017-0048-3","article-title":"Resident fibroblasts in the kidney: a major driver of fibrosis and inflammation","volume":"37","author":"Sato","year":"2017","journal-title":"Inflamm. Regen."},{"key":"10.1016\/j.cbi.2025.111408_bib32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuroscience.2013.10.058","article-title":"Interleukin-1\u03b2 enhances neuronal vulnerability to proNGF-mediated apoptosis by increasing surface expression of p75(NTR) and sortillin","volume":"257","author":"Choi","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.cbi.2025.111408_bib33","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.neuro.2014.09.005","article-title":"Amelioration of cisplatin-induced experimental peripheral neuropathy by a small molecule targeting p75 NTR","volume":"45","author":"Friesland","year":"2014","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.cbi.2025.111408_bib34","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/5454210","article-title":"Dexmedetomidine alleviates lipopolysaccharide-induced acute kidney injury by inhibiting p75NTR-mediated oxidative stress and apoptosis","volume":"2020","author":"Wang","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.cbi.2025.111408_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155252","article-title":"Madecassoside alleviates acute kidney injury by regulating JNK-mediated oxidative stress and programmed cell death","volume":"123","author":"Shan","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.cbi.2025.111408_bib36","article-title":"Dexmedetomidine ameliorates acute stress-induced kidney injury by attenuating oxidative stress and apoptosis through inhibition of the ROS\/JNK signaling pathway","volume":"2018","author":"Chen","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.cbi.2025.111408_bib37","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.intimp.2015.06.020","article-title":"Saikosaponin-D reduces cisplatin-induced nephrotoxicity by repressing ROS-mediated activation of MAPK and NF-\u03baB signalling pathways","volume":"28","author":"Ma","year":"2015","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.cbi.2025.111408_bib38","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/ki.1997.92","article-title":"Endothelin-1 activates c-Jun NH2-terminal kinase in mesangial cells","volume":"51","author":"Araki","year":"1997","journal-title":"Kidney Int."},{"key":"10.1016\/j.cbi.2025.111408_bib39","first-page":"F700","article-title":"Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: apoptosis vs. necrosis","volume":"270","author":"Lieberthal","year":"1996","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.cbi.2025.111408_bib40","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/ki.2011.120","article-title":"Apoptosis and acute kidney injury","volume":"80","author":"Havasi","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.cbi.2025.111408_bib41","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/sj.ki.5002786","article-title":"Cisplatin nephrotoxicity: mechanisms and renoprotective strategies","volume":"73","author":"Pabla","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.cbi.2025.111408_bib42","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/MOP.0000000000001215","article-title":"Pathogenesis of intrinsic acute kidney injury","volume":"35","author":"Devarajan","year":"2023","journal-title":"Curr. Opin. Pediatr."},{"key":"10.1016\/j.cbi.2025.111408_bib43","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s00018-022-04505-w","article-title":"Emerging role of tumor suppressor p53 in acute and chronic kidney diseases","volume":"79","author":"Overstreet","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.cbi.2025.111408_bib44","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.freeradbiomed.2018.11.006","article-title":"N-acetylcysteine ameliorates cisplatin-induced renal senescence and renal interstitial fibrosis through sirtuin1 activation and p53 deacetylation","volume":"130","author":"Li","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cbi.2025.111408_bib45","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1681\/ASN.2008111204","article-title":"siRNA targeted to p53 attenuates ischemic and cisplatin-induced acute kidney injury","volume":"20","author":"Molitoris","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cbi.2025.111408_bib46","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/cdd.2013.51","article-title":"Interplay between p53 and VEGF: how to prevent the guardian from becoming a villain","volume":"20","author":"Haupt","year":"2013","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cbi.2025.111408_bib47","doi-asserted-by":"crossref","first-page":"F983","DOI":"10.1152\/ajprenal.90579.2008","article-title":"Cisplatin-induced apoptosis in p53-deficient renal cells via the intrinsic mitochondrial pathway","volume":"296","author":"Jiang","year":"2009","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.cbi.2025.111408_bib48","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1681\/ASN.V134858","article-title":"Cisplatin induces apoptosis in LLC-PK1 cells via activation of mitochondrial pathways","volume":"13","author":"Park","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cbi.2025.111408_bib49","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ejphar.2006.04.041","article-title":"Down-regulated VEGF expression in the diabetic heart is normalized by an endothelin ETA receptor antagonist","volume":"542","author":"Jesmin","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cbi.2025.111408_bib50","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1177\/1947601911423031","article-title":"Vascular endothelial growth factor (VEGF) and its receptor (vegfr) signaling in angiogenesis: a crucial target for anti- and pro-angiogenic therapies","volume":"2","author":"Shibuya","year":"2011","journal-title":"Genes Cancer"},{"key":"10.1016\/j.cbi.2025.111408_bib51","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1111\/j.1523-1755.2004.00621.x","article-title":"The role of vascular endothelial growth factor (VEGF) in renal pathophysiology","volume":"65","author":"Schrijvers","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.cbi.2025.111408_bib52","doi-asserted-by":"crossref","first-page":"10660","DOI":"10.1074\/jbc.M609048200","article-title":"Phosphorylation of tyrosine 801 of vascular endothelial growth factor receptor-2 is necessary for Akt-dependent endothelial nitric-oxide synthase activation and nitric oxide release from endothelial cells","volume":"282","author":"Blanes","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2025.111408_bib53","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3904\/kjim.2003.18.2.65","article-title":"Role of VEGF in kidney development, microvascular maintenance and pathophysiology of renal disease","volume":"18","author":"Kim","year":"2003","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.cbi.2025.111408_bib54","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1042\/CS20200308","article-title":"Vascular toxicity associated with anti-angiogenic drugs","volume":"134","author":"Neves","year":"2020","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.cbi.2025.111408_bib55","first-page":"13","article-title":"Mechanisms of cisplatin-induced acute kidney injury: pathological mechanisms, pharmacological interventions, and genetic mitigations","author":"McSweeney","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.cbi.2025.111408_bib56","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5049\/EBP.2014.12.2.55","article-title":"Cisplatin-induced kidney dysfunction and perspectives on improving treatment strategies","volume":"12","author":"Oh","year":"2014","journal-title":"Electrolyte Blood Press"},{"key":"10.1016\/j.cbi.2025.111408_bib57","doi-asserted-by":"crossref","first-page":"F218","DOI":"10.1152\/ajprenal.00089.2011","article-title":"Endothelin-A receptor blockade slows the progression of renal injury in experimental renovascular disease","volume":"301","author":"Kelsen","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.cbi.2025.111408_bib58","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.lfs.2012.04.022","article-title":"Reduced NO production rapidly aggravates renal function through the NF-\u03baB\/ET-1\/ETA receptor pathway in DOCA-salt-induced hypertensive rats","volume":"91","author":"Kimura","year":"2012","journal-title":"Life Sci."},{"key":"10.1016\/j.cbi.2025.111408_bib59","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41420-023-01519-6","article-title":"Tim-3 protects against cisplatin nephrotoxicity by inhibiting NF-\u03baB-mediated inflammation","volume":"9","author":"Li","year":"2023","journal-title":"Cell Death Discovery"},{"key":"10.1016\/j.cbi.2025.111408_bib60","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/pr.2018.11","article-title":"Antiproteinuric effect of an endothelin-1 receptor antagonist in puromycin aminonucleoside-induced nephrosis in rat","volume":"83","author":"Kino","year":"2018","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.cbi.2025.111408_bib61","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.biopha.2008.08.004","article-title":"Role of glutathione S-transferase Pi in cisplatin-induced nephrotoxicity","volume":"63","author":"Townsend","year":"2009","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cbi.2025.111408_bib62","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cotox.2017.11.002","article-title":"NF-\u03baB in oxidative stress","volume":"7","author":"Lingappan","year":"2018","journal-title":"Curr Opin Toxicol"},{"key":"10.1016\/j.cbi.2025.111408_bib63","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s12013-014-0231-y","article-title":"Nephroprotective effect of gelsemine against cisplatin-induced toxicity is mediated via attenuation of oxidative stress","volume":"71","author":"Lin","year":"2015","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.cbi.2025.111408_bib64","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.biopha.2018.05.085","article-title":"Protective effects of zingerone on oxidative stress and inflammation in cisplatin-induced rat nephrotoxicity","volume":"105","author":"Alibakhshi","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cbi.2025.111408_bib65","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1681\/ASN.2016070711","article-title":"Long-term endothelin-A receptor antagonism provides robust renal protection in humanized sickle cell disease mice","volume":"28","author":"Kasztan","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cbi.2025.111408_bib66","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1046\/j.1523-1755.2002.00233.x","article-title":"Nitric oxide in acute renal failure: NOS versus NOS","volume":"61","author":"Goligorsky","year":"2002","journal-title":"Kidney Int."},{"key":"10.1016\/j.cbi.2025.111408_bib67","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/bcpt.12538","article-title":"Nebivolol ameliorates cisplatin-induced nephrotoxicity in rats","volume":"118","author":"Morsy","year":"2016","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.cbi.2025.111408_bib68","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s10753-014-9953-7","article-title":"Thalidomide ameliorates cisplatin-induced nephrotoxicity by inhibiting renal inflammation in an experimental model","volume":"38","author":"Amirshahrokhi","year":"2015","journal-title":"Inflammation"},{"key":"10.1016\/j.cbi.2025.111408_bib69","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.fct.2015.01.014","article-title":"Cisplatin-induced renal toxicity via tumor necrosis factor-\u03b1, interleukin 6, tumor suppressor P53, DNA damage, xanthine oxidase, histological changes, oxidative stress and nitric oxide in rats: protective effect of ginseng","volume":"78","author":"Yousef","year":"2015","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.cbi.2025.111408_bib70","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.etp.2008.09.003","article-title":"Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity","volume":"61","author":"Chirino","year":"2009","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.cbi.2025.111408_bib71","doi-asserted-by":"crossref","first-page":"866","DOI":"10.4070\/kcj.2019.0006","article-title":"Effect of ambrisentan therapy on the expression of endothelin receptor, endothelial nitric oxide synthase and NADPH oxidase 4 in monocrotaline-induced pulmonary arterial hypertension rat model","volume":"49","author":"Lee","year":"2019","journal-title":"Korean Circ J"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279725000389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279725000389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T18:20:34Z","timestamp":1740507634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279725000389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":71,"alternative-id":["S0009279725000389"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2025.111408","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of p75NTR\/p53 axis by ambrisentan suppresses apoptosis and oxidative stress-mediated renal damage in a cisplatin AKI model","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2025.111408","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111408"}}